Y Intercept Hong Kong Ltd Sells 4,371 Shares of Cardinal Health, Inc. (NYSE:CAH)

Y Intercept Hong Kong Ltd trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 28.8% in the fourth quarter, HoldingsChannel reports. The firm owned 10,832 shares of the company’s stock after selling 4,371 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Cardinal Health were worth $1,281,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its position in Cardinal Health by 2.1% in the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 52,517 shares of the company’s stock worth $6,211,000 after purchasing an additional 1,100 shares in the last quarter. Sigma Planning Corp grew its position in Cardinal Health by 3.6% in the 4th quarter. Sigma Planning Corp now owns 11,844 shares of the company’s stock worth $1,401,000 after purchasing an additional 413 shares in the last quarter. Transcend Capital Advisors LLC grew its position in shares of Cardinal Health by 3.6% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock valued at $323,000 after acquiring an additional 96 shares during the period. Handelsbanken Fonder AB grew its position in shares of Cardinal Health by 11.6% during the 4th quarter. Handelsbanken Fonder AB now owns 39,783 shares of the company’s stock valued at $4,705,000 after acquiring an additional 4,140 shares during the period. Finally, LMG Wealth Partners LLC grew its position in shares of Cardinal Health by 0.8% during the 4th quarter. LMG Wealth Partners LLC now owns 90,807 shares of the company’s stock valued at $10,740,000 after acquiring an additional 756 shares during the period. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $127.31 on Thursday. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $132.84. The company’s fifty day moving average price is $124.31 and its 200-day moving average price is $117.79. The firm has a market capitalization of $30.75 billion, a price-to-earnings ratio of 23.75, a PEG ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on CAH shares. Deutsche Bank Aktiengesellschaft increased their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research report on Monday, November 4th. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Morgan Stanley increased their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. Evercore ISI raised shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price for the company in a research report on Tuesday, January 7th. Finally, Citigroup increased their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.